Endocyte, Inc. To Announce First Quarter Financial Results on May 9, 2014

DURHAM, N.C., May 2, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it will report financial results for the first quarter ending March 31, 2014, on Friday, May 9, 2014, before the market opens. Chimerix's management team will host a live conference call and audio webcast at 8:30 a.m. ET on Friday, May 9, 2014 to discuss the Company's results and provide a business overview.

Help employers find you! Check out all the jobs and post your resume.